# EDGAR Filing Document

**Accession Number:** 0002068385
**File Stem:** 0001493152-26-007829
**Filing Date:** 2026-2
**Character Count:** 20642
**Document Hash:** 3ceb7c36ddf912fe56c8b9360d983ea6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-007829.hdr.sgml**: 20260224

**ACCESSION NUMBER**: 0001493152-26-007829

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260222

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260224

**DATE AS OF CHANGE**: 20260224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SharonAI Holdings Inc.
- **CENTRAL INDEX KEY:** 0002068385
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43129
- **FILM NUMBER:** 26667722

**BUSINESS ADDRESS:**
- **STREET 1:** 2340 COLLINS AVENUE, SUITE 402
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33141
- **BUSINESS PHONE:** 949-720-7133

**MAIL ADDRESS:**
- **STREET 1:** 2340 COLLINS AVENUE, SUITE 402
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33141

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SharonAI Holdings, Inc.
- **DATE OF NAME CHANGE:** 20251218

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Roth CH Holdings, Inc.
- **DATE OF NAME CHANGE:** 20250513

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (date of earliest event reported): February 22, 2026**

**SHARONAI HOLDINGS INC.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-43129** | **41-2349750** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**745 Fifth Avenue, Suite 500,** 

**New York, NY 10151**

(Address of principal executive offices, including zip code)

**(347) 212-5075**

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instructions A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Class A Ordinary Common Stock, $0.0001 par value | SHAZ | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry into a Material Definitive Agreement.**

The information contained below in Item 5.02 related to the Director Appointment Letter (as defined below) is hereby incorporated by reference into this Item 1.01.

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

On February 22, 2026, the Board of Directors ("the Board") of SharonAI Holdings Inc. (the "Company"), appointed Mr. Benjamin (Ben) Adams to serve as a member of the Board, effective upon his countersigning the Director Appointment Letter (defined below), to fill a vacancy on the Board of Directors.

Mr. Adams was elected as a Class I director and will serve on the Board until the Company's 2026 annual meeting of stockholders at which time he will stand for election alongside the Company's other Class I directors. The Board expects to appoint Mr. Adams to serve as a member of the Nominating and Corporate Governance Committee, the Compensation Committee and the Audit Committee.

Mr. Adams is a public company general counsel, board and CEO adviser and global regulatory leader. He currently serves as the Executive Vice President, Chief Legal Officer and Corporate Secretary of The Western Union Company (NYSE: WU) where he advises its board of directors and board committees on corporate governance, fiduciary duties, SEC disclosure, executive compensation and enterprise risk while also leading Western Union's global legal, regulatory, public policy, ethics and compliance, Intellectual Property and privacy functions. Mr. Adams previously served as the Vice President, Legal at PayPal Inc. (NASDAQ: PYPL), as Assistant General Counsel, Head of Legal Global Consumer Group at Microsoft Corporation (NASDAQ: MSFT), and as Head of Legal, Americas Region at Nokia Corporation (NYSE: NOK). Prior to going in-house, Mr. Adams was an attorney the law firm of Gibson, Dunn & Crutcher LLP.

There is no arrangement or understanding with any person pursuant to which Mr. Adams was appointed as a member of the Board. There are no transactions or relationships between the Company and Mr. Adams that are reportable under Item 404(a) of Regulation S-K. In connection with Mr. Adams' appointment to the Board, Mr. Adams entered into a Director Appointment Letter dated February 22, 2026, with the Company (the "Director Appointment Letter"). Pursuant to the Director Appointment Letter, Mr. Adams will receive: (a) a grant of 10,973 restricted stock units under the Company's 2025 Omnibus Equity Incentive Plan, which vest on the first anniversary of the date of grant; and (b) annual cash compensation of $25,000.

 

*The description of the Director Appointment Letter is only a summary and is qualified in its entirety by reference to the full text of such document, which is filed as an exhibit to this Current Report on Form 8-K and which is incorporated herein by reference.*

**Item 9.01 Financial Statements and Exhibits.**

**(d) *Exhibits.***

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.1 | [Director Appointment Letter by and between Benjamin Adams and SharonAI Holdings Inc. dated February 22, 2026](ex10-1.htm) |
| 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **SHARONAI HOLDINGS, INC.** | **SHARONAI HOLDINGS, INC.** |
|  | By: | */s/ James Manning* |
|  | Name: | James Manning |
|  | Title: | Chief Executive Officer |
| Date: February 24, 2026 |  |  |

---

## Exhibit 10.1

**Exhibit 10.1**

---

| | |
|:---|:---|
| ![](ex10-1_001.jpg) | <br> **SharonAI Holdings Inc**.<br> 745 Fifth Avenue, Suite 500<br> New York, NY 10151 |

---

22 February 2026

BY EMAIL

Mr. Benjamin Adams

17065 Pine Ave

Los Gatos, CA, 95032

USA

bcadamsdc@hotmail.com

**RE: SharonAI Holdings Inc. ("Company")**

Dear Ben,

I am pleased to confirm that following consideration by the Board of Directors of the Company, (the "**Board**"), has approved the contents of this letter agreement for your appointment as a Non-Executive Director subject only to you confirming your acceptance of these terms and conditions.

It is understood that you will not be an employee of the Company.

1. **APPOINTMENT** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 Your
 appointment is subject to the Certificate of Incorporation and By-laws of the Company as is currently in effect and as may be modified
 or amended from time to time (collectively, the "**Constitution** "). Nothing in this letter will be taken to exclude
 or vary the terms of the Constitution as it applies to you as a director of the Company. Your continued service as a director is
 subject to your re-election by the Company's shareholders at the annual stockholders' meeting and to re-election at any
 subsequent annual stockholders' meeting at which either the Constitution requires, or the Board resolves, that you stand for
 re-election.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 Continuation
 of your service as a director is also contingent on satisfactory performance, as determined by the Nomination and Governance Committee
 of the Board, and any relevant statutory provisions relating to the removal of a director.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3 The
 Nomination and Governance Committee of the Board may nominate you to serve for successive term(s), in its discretion and subject
 to your agreement and your re-election at the annual stockholders' meetings in accordance with the Constitution. Notwithstanding
 any mutual expectation, you have no right to re-nomination by the Board, either annually or after any period of time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.4 You
may be appointed to serve on one or more committees of the Board. Your appointments are or will be as follows (until the committees or
the Board decide otherwise):

Audit Committee Invitee <br> Compensation Committee Invitee <br> Nomination and Governance Committee Invitee

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.5 You
 agree to comply with the Code of Ethics, as may be amended from time to time, which is available on the Company website.

Page 1 of 5

---

| | |
|:---|:---|
| ![](ex10-1_001.jpg) | <br> **SharonAI Holdings Inc**.<br> 745 Fifth Avenue, Suite 500<br> New York, NY 10151 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.6 The
 Board may request that you resign from your role as a member of the Board, and you agree to resign, if you:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) commit
 a material breach of your obligations under this letter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) commit
 any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your
 duties to the Company, whether statutory, fiduciary or common law);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) are
 guilty of any fraud or dishonesty or have acted in a manner which, in the opinion of the Company acting reasonably, brings or is
 likely to bring you or the Company into disrepute or is materially adverse to the interests of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) are
 convicted of any criminal offence that results in a material penalty or imprisonment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) are
 restricted or disqualified from acting as a director of any company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) have
 been absent for more than six consecutive months without permission of the Board from meetings of the directors held during that
 period and your alternate director (if any) will not have attended any such meeting in your place during such period and all of your
 co-directors pass a resolution that by reason of such absence you have vacated your office;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) are
 required in writing (whether in electronic form or otherwise) by all your co-directors to resign; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) have
 not complied with the Company's policies or any material applicable laws.

2. **TIME COMMITMENT** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 You
 will be expected to spend a sufficient amount of time as may be necessary to adequately prepare for and attend any meetings of the
 Board and its committees as may be called from time to time. You will be expected to devote such time as is necessary for the proper
 performance of your duties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 The
 nature of the role makes it impossible to be specific about the maximum time commitment, and there is always the possibility of additional
 time commitment in respect of preparation time and ad hoc matters which may arise from time to time, and particularly when the Company
 is undergoing a period of increased activity. At certain times it may be necessary to convene additional Board, committee, or shareholder
 meetings.

3. **FEES AND EXPENSES** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1 You
 will be paid an annual fee of $25,000 (USD) gross (current at the date of this letter) ()"**Cash Compensation** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2 In
 addition, you will granted 10,973 Restricted Stock Units which will vest on the first anniversary of the date of grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3 Fees
 will be subject to periodic review by the compensation committee of the Board

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4 The
 Company will reimburse you for all reasonable and properly-documented expenses you incur in performing the duties of your office.
 The procedure and other guidance in respect of expense claims is set out in the Company's guide relating to expense claims
 from time to time or, if no such guide is in place, as agreed with the Chairman of the Board.

Page 2 of 5

---

| | |
|:---|:---|
| ![](ex10-1_001.jpg) | <br> **SharonAI Holdings Inc**.<br> 745 Fifth Avenue, Suite 500<br> New York, NY 10151 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5 Unless
 otherwise agreed between you and the compensation committee of the Board, on termination of your services as a director you will
 only be entitled to such fees as may have accrued to the date of termination, together with reimbursement in the normal way of any
 expenses properly incurred prior to that date.

4. **INDEPENDENCE AND OUTSIDE INTERESTS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 The
 Board of the Company has determined you to be independent, taking account of the guidance contained in Nasdaq Rule 5605 and IM-5605,
 and taking into account exemptions thereto at Nasdaq Rule 5615.<sup>5</sup>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 Notwithstanding
 the foregoing, you acknowledge the importance of avoiding conflicts of interest and the appearance of conflicts of interest. Accordingly,
 you have disclosed all present or currently existing conflicts and agree to disclose to the Company any future commitments, whether
 such commitments create potential or actual conflicts of interest or the appearance of any conflicts. In the event that you become
 aware of any further potential or actual conflicts of interest, these should be disclosed to the Chairman as soon as they become
 apparent, and the agreement of the Board may have to be sought. You should immediately recuse yourself from decision making on any
 matter on which there is a conflict.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3 You
 represent to the Company that the performance of your duties as a director of the Company do not and will not violate any agreement
 or obligation, whether written or not, that you may have with or to any person.

5. **CONFIDENTIALITY** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1 You
 acknowledge that as a director you will have fiduciary duties to the Company, which include, but are not limited to keeping all information
 acquired during your appointment confidential and not be releasing, communicating, or disclosing it either during your service or
 after you stop serving at a director, to third parties without my prior clearance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.2 You
 acknowledge the need to hold and retain Company information (in whatever format you may receive it) under appropriately secure conditions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.3 You
 will notify the Company promptly if you are subpoenaed or otherwise served with legal process in any manner involving the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.4 In
 the event of any claim or litigation against the Company, or any officer, employee, or director of the Company, based upon any alleged
 conduct, acts or omissions, you will cooperate with the Company and provide to the Company such information and documents in your
 possession or control as are necessary and reasonably requested by the Company or its counsel.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.5 Nothing
 in this paragraph will prevent you from disclosing information which you are entitled or required to disclose under any statutory
 provision, provided that the disclosure is made in accordance with the provisions of such statutory provision.

Page 3 of 5

---

| | |
|:---|:---|
| ![](ex10-1_001.jpg) | <br> **SharonAI Holdings Inc**.<br> 745 Fifth Avenue, Suite 500<br> New York, NY 10151 |

---

6. **DEALING IN THE COMPANY'S SHARES, FILINGS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 You
 agree to comply with the insider trading policy, as may be amended from time to time, which is available on the Company website.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 You
 agree to give prior notice to the Company of any trades you intend to make in the Company's stock, and the assist the Company
 with any necessary filings.

7. **REVIEW PROCESS** 

The performance of individual directors and the whole Board and its committees is evaluated annually.

8. **INDEPENDENT PROFESSIONAL ADVICE** 

Circumstances may occur when, in the execution of your duties as a director, it will be appropriate for you to seek advice from independent advisers at the Company's expense. With the approval of the Chairman, the Company will reimburse the reasonable cost of expenditure incurred by you in such circumstances in accordance with any policy in effect from time to time.

Copies of this advice would normally be expected to be made available to, and for the benefit of all Board members, unless otherwise agreed by the Chairman.

All directors have direct access to the General Counsel / Corporate Secretary for advice and assistance where appropriate. If you wish to contact a member of the Company's management, the Corporate Secretary is available to facilitate that meeting for you.

9. **CHANGES TO PERSONAL DETAILS** 

You will advise the Corporate Secretary promptly of any change in address or other personal contact details.

10. **RETURN OF PROPERTY** 

Upon termination of your service as a director of the Company (for whatever cause), you will deliver to the Company or destroy, at the Company's discretion, all documents, records, papers, or other Company property which may be in your possession or under your control, and which relate in any way to the Company's business affairs, and you will not retain any copies thereof.

Page 4 of 5

---

| | |
|:---|:---|
| ![](ex10-1_001.jpg) | <br> **SharonAI Holdings Inc**.<br> 745 Fifth Avenue, Suite 500<br> New York, NY 10151 |

---

If you are agreeable to accepting your appointment on the foregoing terms and conditions, I would ask you to sign and return one copy of this letter to me.

---

| |
|:---|
| Yours sincerely, |
| */s/ James Manning* |
| Chairman of the Board<br> SharonAI Holdings Inc |

---

I confirm and agree to the terms of my appointment as a non-executive director of the Company as set out in this letter.

---

| |
|:---|
| */s/ Benjamin C. Adams* |
| Benjamin C. Adams |
| Date: 23/02/2026 |

---

Page 5 of 5